George Giannakoulas: NLR as a Predictor of Outcomes in Acute Coronary Syndromes
George Giannakoulas, Adjunct Associate Professor at Institute of Bioelectronic Medicine, Feinstein Institutes of Medical Research, shared a post on LinkedIn about a recent article he and his colleagues co-authored, published in Coronary Artery Disease, adding:
“I am pleased to share our latest publication in Coronary Artery Disease: ‘Neutrophil-to-lymphocyte ratio and clinical outcomes across the acute coronary syndrome trajectory: insights from the CardioMining Study.’
Using data from 4,927 patients with acute coronary syndromes, we examined the prognostic value of the neutrophil-to-lymphocyte ratio (NLR)—a simple, inexpensive and routinely available marker of inflammation.
Higher NLR at admission was independently associated with:
- Greater long-term all-cause mortality
- More in-hospital complications
- Longer hospital stays.
The study also reflects the ambition behind CardioMining: using artificial intelligence to harness real-world clinical data, answer meaningful cardiovascular research questions and generate evidence relevant to clinical practice.
Congratulations and thanks to all co-authors and collaborators for their contributions and continued commitment to CardioMining!”
Title: Neutrophil-to-lymphocyte ratio and clinical outcomes across the acute coronary syndrome trajectory: insights from the CardioMining Study
Authors: Evangelia Alexandrou, Vasiliki Patsiou, Athanasios Samaras, Andreas Papazoglou, Dimitrios Moysidis, Antonios Barmpagiannos, Thomas Strymponis, Antonios Ziakas, Grigorios Tsigkas, Nikolaos Fragakis, Ioannis Zarifis, Dimitrios N Tziakas, Periklis Davlouros, Konstantinos Tsioufis, George Giannakoulas
Stay updated with Hemostasis Today.
-
Nov 5, 2026, 18:02Kellie Machlus: Bone Marrow Megakaryocytes Present Antigens and Regulate T Cells
-
Nov 5, 2026, 14:42Matteo Foschi: ASPERA-R Reveals the Challenges of Anticoagulation Resumption After Hemorrhagic Transformation
-
Nov 5, 2026, 14:30Khaled Musallam: Assessing the State of Thalassaemia and Sickle Cell Disease Care Across Europe
-
Nov 5, 2026, 14:17Joshua Muia: The Evolution of ADAMTS13 Research
-
Nov 5, 2026, 14:02Paulo Colimodio: Scientific Highlights from the XVII Argentine Congress of Hemostasis and Thrombosis
-
Nov 5, 2026, 13:52Emmanuel J Favaloro: STH Reports 2025 Impact Factor and Most Highly Cited Papers
-
Nov 5, 2026, 13:48David McIntosh: Plasma Progress – Reaching the 80% of Patients Still Left Behind
-
Nov 5, 2026, 13:42Hélène Gleitz-Broeders: How MPNs Reshape the Bone Marrow Microenvironment
-
Nov 5, 2026, 13:40Augustina Isioma Ikusemoro: The Role of Blood Conservation in PBM